Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Assi

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Case Reports in Vascular Medicine|January 29, 2016
Isolated Celiac and Splenic Artery Dissection: A Case Report and Review of the LiteratureTania Moussa, Georges Nawfal, Tarek Assi, et al.
Cancers|April 12, 2022
Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q CodeletionYingping Li, Samy Ammari, Littisha Lawrance, et al.
Future Oncology (London, England)|January 24, 2019
Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neckElie El Rassy, Tarek Assi, Ziad Bakouny, et al.
Future Oncology (London, England)|April 24, 2020
What the oncologist needs to know about COVID-19 infection in cancer patientsElie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, et al.
Pharmacogenomics|December 15, 2025
Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insightTarek Assi, Tania Moussa, Cendrella Bou-Orm, et al.
World Journal of Gastroenterology|December 29, 2016
Dilemma of first line regimens in metastatic pancreatic adenocarcinomaMarwan Ghosn, Tony Ibrahim, Tarek Assi, et al.
Anti-Cancer Drugs|October 15, 2019
Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patientFadi Farhat, Mohammad Tarabaih, Ali Kanj, et al.
Cells|June 2, 2021
Targeting the VEGF Pathway in OsteosarcomaTarek Assi, Sarah Watson, Bachar Samra, et al.
Immunotherapy|September 7, 2018
The current state of immune checkpoint inhibitors in the first-line treatment of renal cancerElie El Rassy, Rita Maria Khoury Abboud, Nathalie Ibrahim, et al.
Seminars in Oncology|March 24, 2020
TRK inhibition in soft tissue sarcomas: A comprehensive reviewTarek Assi, Elie Rassy, Hussein Nassereddine, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Case Reports in Vascular Medicine|January 29, 2016
Isolated Celiac and Splenic Artery Dissection: A Case Report and Review of the LiteratureTania Moussa, Georges Nawfal, Tarek Assi, et al.
Cancers|April 12, 2022
Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q CodeletionYingping Li, Samy Ammari, Littisha Lawrance, et al.
Future Oncology (London, England)|January 24, 2019
Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neckElie El Rassy, Tarek Assi, Ziad Bakouny, et al.
Future Oncology (London, England)|April 24, 2020
What the oncologist needs to know about COVID-19 infection in cancer patientsElie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, et al.
Pharmacogenomics|December 15, 2025
Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insightTarek Assi, Tania Moussa, Cendrella Bou-Orm, et al.
World Journal of Gastroenterology|December 29, 2016
Dilemma of first line regimens in metastatic pancreatic adenocarcinomaMarwan Ghosn, Tony Ibrahim, Tarek Assi, et al.
Anti-Cancer Drugs|October 15, 2019
Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patientFadi Farhat, Mohammad Tarabaih, Ali Kanj, et al.
Cells|June 2, 2021
Targeting the VEGF Pathway in OsteosarcomaTarek Assi, Sarah Watson, Bachar Samra, et al.
Immunotherapy|September 7, 2018
The current state of immune checkpoint inhibitors in the first-line treatment of renal cancerElie El Rassy, Rita Maria Khoury Abboud, Nathalie Ibrahim, et al.
Seminars in Oncology|March 24, 2020
TRK inhibition in soft tissue sarcomas: A comprehensive reviewTarek Assi, Elie Rassy, Hussein Nassereddine, et al.
Pageof 12